blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3765458

EP3765458 - O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLYCOPYRANOSIDASE INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.11.2023
Database last updated on 13.07.2024
FormerThe patent has been granted
Status updated on  09.12.2022
FormerGrant of patent is intended
Status updated on  24.07.2022
FormerExamination is in progress
Status updated on  01.10.2021
FormerRequest for examination was made
Status updated on  18.12.2020
FormerThe international publication has been made
Status updated on  21.09.2019
Formerunknown
Status updated on  08.04.2019
Most recent event   Tooltip16.02.2024Lapse of the patent in a contracting state
New state(s): BE, SI		published on 20.03.2024  [2024/12]
Applicant(s)For all designated states
Biogen MA Inc.
225 Binney Street
Cambridge, MA 02142 / US
[2021/03]
Inventor(s)01 / GENUNG, Nathan
c/o Biogen MA Inc.
225 Binney Street
Cambridge, MA 02142 / US
02 / GUCKIAN, Kevin M.
c/o Biogen MA Inc.
225 Binney Street
Cambridge, MA 02142 / US
03 / VESSELS, Jeffrey
c/o Biogen MA Inc.
225 Binney Street
Cambridge, MA 02142 / US
04 / ZHANG, Lei
c/o Biogen MA Inc.
225 Binney Street
Cambridge, MA 02142 / US
05 / GIANATASSIO, Ryan
c/o Biogen MA Inc.
225 Binney Street
Cambridge, MA 02142 / US
06 / LIN, Edward Yin Shiang
c/o Biogen MA Inc.
225 Binney Street
Cambridge, MA 02142 / US
07 / XIN, Zhili
c/o Biogen MA Inc.
225 Binney Street
Cambridge, MA 02142 / US
 [2021/03]
Representative(s)HGF
HGF Limited
1 City Walk
Leeds LS11 9DX / GB
[2023/02]
Former [2021/03]HGF
1 City Walk
Leeds LS11 9DX / GB
Application number, filing date19713945.413.03.2019
[2021/03]
WO2019US21995
Priority number, dateUS201862642932P14.03.2018         Original published format: US 201862642932 P
US201862690536P27.06.2018         Original published format: US 201862690536 P
US201862699443P17.07.2018         Original published format: US 201862699443 P
[2021/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019178191
Date:19.09.2019
Language:EN
[2019/38]
Type: A1 Application with search report 
No.:EP3765458
Date:20.01.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 19.09.2019 takes the place of the publication of the European patent application.
[2021/03]
Type: B1 Patent specification 
No.:EP3765458
Date:11.01.2023
Language:EN
[2023/02]
Search report(s)International search report - published on:EP19.09.2019
ClassificationIPC:C07D417/06, C07D417/14, C07D495/04, A61P25/28, A61K31/427, A61K31/445
[2021/03]
CPC:
A61P25/28 (EP); C07D417/14 (EP,US); C07D417/06 (US);
C07D471/04 (US); C07D495/04 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/03]
Extension statesBA08.10.2020
ME08.10.2020
Validation statesKH08.10.2020
MA08.10.2020
MD08.10.2020
TN08.10.2020
TitleGerman:O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLYCOPYRANOSIDASE-INHIBITOREN[2021/03]
English:O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLYCOPYRANOSIDASE INHIBITORS[2021/03]
French:INHIBITEURS D'O-GLYCOPROTÉINE-2-ACÉTAMIDO-2-DÉSOXY-3-D-GLYCOPYRANOSIDASE[2021/03]
Entry into regional phase08.10.2020National basic fee paid 
08.10.2020Designation fee(s) paid 
08.10.2020Examination fee paid 
Examination procedure08.10.2020Examination requested  [2021/03]
08.10.2020Date on which the examining division has become responsible
07.05.2021Amendment by applicant (claims and/or description)
05.10.2021Despatch of a communication from the examining division (Time limit: M06)
04.04.2022Reply to a communication from the examining division
25.07.2022Communication of intention to grant the patent
01.12.2022Fee for grant paid
01.12.2022Fee for publishing/printing paid
01.12.2022Receipt of the translation of the claim(s)
Divisional application(s)EP23151036.3  / EP4186899
Opposition(s)12.10.2023No opposition filed within time limit [2023/51]
Fees paidRenewal fee
08.10.2020Renewal fee patent year 03
16.02.2022Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT11.01.2023
CZ11.01.2023
DK11.01.2023
EE11.01.2023
FI11.01.2023
HR11.01.2023
LT11.01.2023
LV11.01.2023
MC11.01.2023
NL11.01.2023
PL11.01.2023
RO11.01.2023
RS11.01.2023
SE11.01.2023
SI11.01.2023
SK11.01.2023
SM11.01.2023
IE13.03.2023
LU13.03.2023
BE31.03.2023
CH31.03.2023
LI31.03.2023
NO11.04.2023
GR12.04.2023
IS11.05.2023
PT11.05.2023
[2024/11]
Former [2024/09]AT11.01.2023
CZ11.01.2023
DK11.01.2023
EE11.01.2023
FI11.01.2023
HR11.01.2023
LT11.01.2023
LV11.01.2023
MC11.01.2023
NL11.01.2023
PL11.01.2023
RO11.01.2023
RS11.01.2023
SE11.01.2023
SK11.01.2023
SM11.01.2023
IE13.03.2023
LU13.03.2023
CH31.03.2023
LI31.03.2023
NO11.04.2023
GR12.04.2023
IS11.05.2023
PT11.05.2023
Former [2024/08]AT11.01.2023
CZ11.01.2023
DK11.01.2023
EE11.01.2023
FI11.01.2023
HR11.01.2023
LT11.01.2023
LV11.01.2023
MC11.01.2023
NL11.01.2023
PL11.01.2023
RO11.01.2023
RS11.01.2023
SE11.01.2023
SK11.01.2023
SM11.01.2023
IE13.03.2023
LU13.03.2023
NO11.04.2023
GR12.04.2023
IS11.05.2023
PT11.05.2023
Former [2024/02]AT11.01.2023
CZ11.01.2023
DK11.01.2023
EE11.01.2023
FI11.01.2023
HR11.01.2023
LT11.01.2023
LV11.01.2023
MC11.01.2023
NL11.01.2023
PL11.01.2023
RO11.01.2023
RS11.01.2023
SE11.01.2023
SK11.01.2023
SM11.01.2023
LU13.03.2023
NO11.04.2023
GR12.04.2023
IS11.05.2023
PT11.05.2023
Former [2023/50]AT11.01.2023
CZ11.01.2023
DK11.01.2023
EE11.01.2023
FI11.01.2023
HR11.01.2023
LT11.01.2023
LV11.01.2023
MC11.01.2023
NL11.01.2023
PL11.01.2023
RO11.01.2023
RS11.01.2023
SE11.01.2023
SK11.01.2023
SM11.01.2023
NO11.04.2023
GR12.04.2023
IS11.05.2023
PT11.05.2023
Former [2023/49]AT11.01.2023
CZ11.01.2023
DK11.01.2023
EE11.01.2023
FI11.01.2023
HR11.01.2023
LT11.01.2023
LV11.01.2023
MC11.01.2023
NL11.01.2023
PL11.01.2023
RO11.01.2023
RS11.01.2023
SE11.01.2023
SM11.01.2023
NO11.04.2023
GR12.04.2023
IS11.05.2023
PT11.05.2023
Former [2023/48]AT11.01.2023
DK11.01.2023
EE11.01.2023
FI11.01.2023
HR11.01.2023
LT11.01.2023
LV11.01.2023
MC11.01.2023
NL11.01.2023
PL11.01.2023
RS11.01.2023
SE11.01.2023
SM11.01.2023
NO11.04.2023
GR12.04.2023
IS11.05.2023
PT11.05.2023
Former [2023/46]AT11.01.2023
DK11.01.2023
FI11.01.2023
HR11.01.2023
LT11.01.2023
LV11.01.2023
NL11.01.2023
PL11.01.2023
RS11.01.2023
SE11.01.2023
SM11.01.2023
NO11.04.2023
GR12.04.2023
IS11.05.2023
PT11.05.2023
Former [2023/39]AT11.01.2023
FI11.01.2023
HR11.01.2023
LT11.01.2023
LV11.01.2023
NL11.01.2023
PL11.01.2023
RS11.01.2023
SE11.01.2023
NO11.04.2023
GR12.04.2023
IS11.05.2023
PT11.05.2023
Former [2023/38]AT11.01.2023
FI11.01.2023
HR11.01.2023
LT11.01.2023
LV11.01.2023
NL11.01.2023
PL11.01.2023
RS11.01.2023
SE11.01.2023
NO11.04.2023
GR12.04.2023
PT11.05.2023
Former [2023/37]AT11.01.2023
FI11.01.2023
HR11.01.2023
LT11.01.2023
LV11.01.2023
NL11.01.2023
RS11.01.2023
SE11.01.2023
NO11.04.2023
GR12.04.2023
PT11.05.2023
Former [2023/36]AT11.01.2023
FI11.01.2023
HR11.01.2023
LT11.01.2023
LV11.01.2023
NL11.01.2023
RS11.01.2023
SE11.01.2023
NO11.04.2023
PT11.05.2023
Former [2023/35]AT11.01.2023
HR11.01.2023
LT11.01.2023
NL11.01.2023
RS11.01.2023
NO11.04.2023
PT11.05.2023
Former [2023/34]LT11.01.2023
NL11.01.2023
RS11.01.2023
PT11.05.2023
Former [2023/33]LT11.01.2023
NL11.01.2023
Former [2023/31]NL11.01.2023
Cited inInternational search[I]WO2014159234  (MERCK PATENT GMBH [DE], et al);
 [A]WO2017106254  (MERCK SHARP & DOHME [US], et al);
 [XP]WO2018109202  (JANSSEN PHARMACEUTICA NV [BE]);
 [XP]WO2018109198  (JANSSEN PHARMACEUTICA NV [BE]);
 [XP]WO2018154133  (JANSSEN PHARMACEUTICA NV [BE])
by applicantUS4938949
 WO2013075083
 WO2013075084
 WO2013078320
 WO2013120104
 WO2014124418
 WO2014151142
 WO2015023915
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.